Combat or surveillance? Evaluation of the heterogeneous inflammatory breast cancer microenvironment

Journal of Pathology

Volumn 229, Issue 4, 2013, Pages 569-578

  Krüger, Juliane M ^a,e   Wemmert, Cédric ^b   Sternberger, Ludovic ^a,e   Bonnas, Christel ^a,e   Dietmann, Gabriele ^a,e   Gançarski, Pierre ^b   Feuerhake, Friedrich ^a,c,d,e  

^a ROCHE INNOVATION CENTER MUNICH   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

breast cancer; image analysis; tumour infiltrating lymphocytes

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; PERFORIN;

ARTICLE; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CELL DENSITY; CELL HETEROGENEITY; CELL POPULATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOLECULAR INTERACTION; PRIORITY JOURNAL; TUMOR CELL; TUMOR MICROENVIRONMENT;

ALGORITHMS; CLUSTER ANALYSIS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BREAST NEOPLASMS; MACROPHAGES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SOFTWARE; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84874061445     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4150     Document Type: Article

References (38)

1. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
2. Schreiber RD, Old LJ, Smyth MJ,. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570.
3. Biswas SK, Mantovani A,. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
4. Steidl C, Lee T, Shah SP, et al,. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010; 362: 875-885.
5. Fujiwara T, Fukushi J, Yamamoto S, et al,. Macrophage infiltration predicts a poor prognosis for human Ewing sarcoma. Am J Pathol 2011; 179: 1157-1170.
6. FridmanWH, Galon J, Pages F, et al,. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res 2011; 71: 5601-5605.
7. Galon J, Pages F, Marincola FM, et al,. The immune score as a new possible approach for the classification of cancer. J Transl Med 2012; 10: 1.
8. Mlecnik B, Tosolini M, Kirilovsky A, et al,. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011; 29: 610-618.
9. Pardoll DM,. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252-264.
10. Galon J, Franck P, Marincola FM, et al,. Cancer classification using the immunoscore: a worldwide task force. J Transl Med 2012; 10: 205.
11. Mohammed ZM, Going JJ, Edwards J, et al,. The relationship between components of tumour inflammatory cell and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer 2012; 107: 864-955.
12. + T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade. Histopathology 2011; 58: 1107-1116.
13. Denkert C, Loibl S, Noske A, et al,. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28: 105-113.
14. + lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011; 29: 1949-1955.
15. + regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 2011; 130: 645-655.
16. Ladoire S, Arnould L, Mignot G, et al,. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 2011; 125: 65-72.
17. Mohammed ZM, Going JJ, Edwards J, et al,. The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treat Rev 2012; 38: 943-955.
18. Hall M, Frank E, Holmes G, et al,. The WEKA data mining software: an update. SIGKDD Explorations 2009; 11: 1-18.
19. Lloyd SP,. Least square quantization in PCM. Bell Telephone Laboratories Paper 1957. IEEE Trans Inf Theory 1982; 28: 129-137.
20. Macqueen JB,. Some methods for classification and analysis of multivariate observations. In Proceedings of the Fifth Berkeley Symposium on Math, Statistics, and Probability. Uni Calif Press 1967; 1: 281-297.
21. Dempster AP, Laird NM, Rubin DB,. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc 1977; 39: 1-38.
22. R Core Team,. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2012; ISBN 3-900051-07-0; URL http://www.R-project.org/
23. Lin LI,. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-268.
24. Quinn C, Haber MJ, Pan Y,. Use of the concordance correlation coefficient when examining agreement in dyadic research. Nurs Res 2009; 58: 368-373.
25. De Saint Basile G, Ménasché G, Fischer A,. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 2012; 10: 568-579.
26. + T cells. Nat Rev Immunol 2011; 11: 645-657.
27. Underhill DM, Goodridge HS,. Information processing during phagocytosis. Nat Rev Immunol 2012; 12: 492-502.
28. Lin F, Butcher EC,. Modeling the role of homologous receptor desensitization in cell gradient sensing. J Immunol 2008; 181: 8335-8343.
29. Chauveau A, Aucher A, Eissmann P, et al,. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci USA 2010; 107: 5545-5550.
30. + T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med 2010; 207: 223-235.
31. Daldrup-Link HE, Golovko D, Ruffell B, et al,. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res 2011; 17: 5695-5704.
32. Yuan Y, Failmezger H, Rueda OM, et al,. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 2012; 4: 157ra143.
33. West NR, Milne K, Truong PT, et al,. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res 2011; 13: R126.
34. Curtis C, Shah SP, Chin SF, et al,. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352.
35. Wu JM, Beck AH, Pate LL, et al,. Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes. Clin Cancer Res 2011; 17: 437-446.
36. Beck AH, Sangoi AR, Leung S, et al,. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 2011; 3: 108ra113.
37. Martinet L, Garrido I, Filleron T, et al,. Human solid tumors contain high endothelial venules: association with T and B lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71: 5678-5687.
38. Ogino S, Galon J, Fuchs CS, et al,. Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol 2011; 8: 711-719.